Companies/US/NAOV

ENVUE MEDICAL, INC.

Income flow

Annual
NAOV 10-K Income StatementPeriod 2025-12-31Source 10-K
Nano Vibronix$2MEnvue$696,000Revenue$3MGross profit$153,000Cost of revenue$2M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$3M
  • Nano Vibronix$2M72.7%
  • Envue$696,00027.3%
By geography
By geography$3M
  • United States$3M98.3%
  • Australia New Zealand$20,0000.8%
  • Other Country$15,0000.6%
  • Europe$8,0000.3%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0Shares outTotal shares currently outstanding (issued and not retired).923,717FloatShares available to trade — outstanding minus closely held (insiders, strategic holders).859,206
Stock splits
  1. 1:122026-09-01
  2. 1:102025-08-12
  3. 1:112025-03-14
  4. 1:202023-02-09